Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals
Materials Today Bio · 2023-10 · 22 · 100756
DOI: 10.1016/j.mtbio.2023.100756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2023-10. Verfasst von Pengyu Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Technology, Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beiji…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
Indigo naturalis (IN) has been extensively used as a topical treatment for psoriasis. However, clinical applications of IN in ointment were hampered by its limited transdermal efficiency and dark stains. To address the aforementioned issues, nanopatches carrying IN were fabricated using poly(ε-caprolactone, PCL)/poly(ethylene oxide, PEO) and topically applied to psoriasiform skin. The ideal ratio of 5% PCL/PEO was established to be 80:20 (w/w), and 15% IN as payload was confirmed. Investigations on the three principal active components of IN release indicated that indirubin and tryptanthrin were released in bursts, while indigo was released in a limited and controlled manner. Further biological analyses confirmed a favorable biocompatibility of amphiphilic IN-PCL/PEO, which coincided with the intended therapeutic outcomes as measured by severity index scoring and pathological evaluations in vivo. The advantages of IN as nanopatches over ointment could be due to improved transdermal distribution of indirubin and tryptanthrin, resulting in effective management of epidermal hyperplasia and blood vessel remodeling. Meanwhile, due to the lower preservation of epidermal indigo, IN-PCL/PEO nanopatches caused no skin coloration. Similarly, during a 4-week topical treatment of IN-PCL/PEO nanopatches, the safety and anti-psoriatic benefits were obtained in an initial human test. The conversion of IN from topical cream to electrospun nanofibers opens up new avenues for bench-to-bedside translation of this herbal therapy and provides mechanistic insight into IN's roles in the management of psoriasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering and Technology, Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
- Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, College of Chemistry and Materials Science, Hebei University, Baoding, 071002, China.
- National Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing, 211100, China.
Förderung
- China Academy of Chinese Medical Sciences
Zitieren
APA
Wang, P., Gao, J., Guo, S., Liu, H., Cao, C., Hong, S., Sun, Y., Wang, C., Xiao, W., Song, P., Li, N., & Xu, R. (2023). Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals. Materials Today Bio, 22, 100756. https://doi.org/10.1016/j.mtbio.2023.100756
Vancouver
Wang P, Gao J, Guo S, Liu H, Cao C, Hong S, et al. Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals. Materials Today Bio. 2023;22:100756. doi:10.1016/j.mtbio.2023.100756
BibTeX
@article{Wang2023,
author = {Wang, Pengyu and Gao, Junwei and Guo, Shijie and Liu, Hongmei and Cao, Can and Hong, Shihao and Sun, Yu and Wang, Chen and Xiao, Wei and Song, Ping and Li, Ning and Xu, Ruodan},
title = {Benefits of topical indigo naturalis nanofibrous patch on psoriatic skin: A transdermal strategy for botanicals},
journal = {Materials Today Bio},
year = {2023},
volume = {22},
pages = {100756},
doi = {10.1016/j.mtbio.2023.100756}
}
EUVIMED